Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.

Patients lacking high molecular weight (HMW) kininogen have profound abnormalities of the Hageman factor-dependent pathways of coagulation, kinin formation, and fibrinolysis. The ability of HMW kininogen to potentiate the Hageman factor fragments (HFf) activation of prekallikrein and Factor XI in pl...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Invest
Egile Nagusiak:	Liu, C Y, Scott, C F, Bagdasarian, A, Pierce, J V, Kaplan, A P, Colman, R W
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Clinical Investigation 1977
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC372338/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/874091/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI108770
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!